Dr. Ekaterine Berishvili is head of the Tissue Engineering and Organ Regeneration lab at the University of Geneva and director of the Cell Isolation and Transplantation Center at the University Hospitals of Geneva. Her area of expertise is mainly focused on innovative cell-based therapies for type 1 diabetes, immune tolerance induction strategies and tissue engineering. She is a board member of the European Society of Transplantation (ESOT) and Cell Transplant and Regenerative Medicine Society (CTRMS), a member of various scientific committees, and part of the JDRF beta cell replacement consortium.